Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs)
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Fijolek (Warsaw, Poland), E. Wiatr (Warsaw, Poland), V. Petroniec (Warsaw, Poland), E. Augustynowicz-Kopec (Warsaw, Poland), M. Bednarek (Warsaw, Poland), D. Gawryluk (Warsaw, Poland), M. Martusewicz-Boros (Warsaw, Poland), K. Modrzewska (Warsaw, Poland), E. Radzikowska (Warsaw, Poland), K. Roszkowski-Sliz (Warsaw, Poland). The presence of  staphylococcal superantigens in nasal swabs and correlation with activity of granulomatosis with polyangiitis (GPA) in own material.. 3035

Member's Comments

No comment yet.

Related content which might interest you: Granulomatosis with polyangiitis (Wegener&s) Source: Eur Respir Mon 2011; 54: 1-14 Year: 2011 New biomarkers for early diagnosis of eosinophilic granulomatosis with polyangiitis (EGPA) Source: International Congress 2017 – Techniques to treat asthma Year: 2017 Lung-limited Granulomatosis with polyangiitis (GPA) managed without immunosuppression Source: International Congress 2018 – CC5 Pulmonary vasculitis: the great chameleon Year: 2018 Wegener‘s granulomatosis (WG) limited to the lungs Source: Eur Respir J 2004; 24: Suppl. 48, 49s Year: 2004 Frequency of eosinophilic granulomatosis with polyangiitis in Europe by meta-analysis Source: Virtual Congress 2020 – Prevalence and incidence of chronic lung diseases Year: 2020 Involvement of the respiratory tract in granulomatosis with polyangiitis - bronchoscopic point of view Source: International Congress 2019 – Interventional pulmonology: diagnostic techniques and obstructive airway disease Year: 2019 Steroid-sparing effects of benralizumab in patients with eosinophilic granulomatosis with polyangiitis Source: ERJ Open Res, 6 (4) 00451-2020; 10.1183/23120541.00451-2020 Year: 2020 Physiological characteristics in patients with microscopic polyangitis (MPA) and wegener‘s granulomatosis (WG) Source: Eur Respir J 2004; 24: Suppl. 48, 327s Year: 2004 Wegener's granulomatosis (WG) - clinical features and response to treatment in 18 cases Source: Eur Respir J 2002; 20: Suppl. 38, 64s Year: 2002 Coexistent granulomatosis with polyangiitis (Wegener‘s) and Crohn disease: A clinicopathologic description of cases Source: Annual Congress 2012 - Pulmonary manifestations of systemic diseases Year: 2012 Eosinophilic granulomatosis with polyangiitis Source: Eur Respir Monogr 2019; 86: 188-209 Year: 2019 Eosinophilic granulomatosis with polyangiitis Source: Eur Respir Monogr 2022; 95: 177-192 Year: 2022 Neutrophil chemotaxis in granulomatosis with polyangiitis (Wegener’s) and idiopathic pulmonary fibrosis Source: Eur Respir J 2011; 38: 1081-1088 Year: 2011 Biologics for eosinophilic granulomatosis with polyangiitis Source: Short video statement 2020 Year: 2020 Alveolar haemorrhage syndromes Source: Eur Respir Mon 2011; 54: 15-31 Year: 2011 Microscopic polyangiitis and granulomatosis with polyangiitis Source: Eur Respir Monogr 2019; 86: 153-172 Year: 2019 Respiratory manifestations of eosinophilic granulomatosis with polyangiitis (Churg–Strauss) Source: Eur Respir J 2016; 48: 1429-1441 Year: 2016 Different disease subtypes in allergic eosinophilic granulomatosis with polyangiitis (EGPA) Source: Annual Congress 2013 –Clinical management of orphan lung diseases Year: 2013 Aerosolized tobramycin in patients with Wegener's granulomatosis Source: Eur Respir J 2001; 18: Suppl. 33, 138s Year: 2001 Wegener granulomatosis : review of 16 cases Source: Eur Respir J 2002; 20: Suppl. 38, 314s Year: 2002